Last reviewed · How we verify
Sepsis of the newborn
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Penicillin G Potassium In Plastic Container · Pfizer
- Tobi · Novartis
- Vancocin · ANI Pharmaceuticals
- Claforan · Sterimax
- Vantobra · Pfizer
- Gentamicin · Merck & Co.
- Nebcin · University Hospital, Lille
- Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - penicillin · Karlstad University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Sepsis of the newborn patent landscape — cliff calendar, originator estates, attackable patents
- Sepsis of the newborn treatment landscape brief
- Sepsis of the newborn treatment updates RSS
Frequently asked questions about Sepsis of the newborn
What drugs treat Sepsis of the newborn?
Tracked treatments include Ramycin, Garamycin, Penicillin G Potassium In Plastic Container, Tobi, Vancocin, Claforan, Vantobra, Gentamicin.
What is the treatment for Sepsis of the newborn?
Standard treatment for Sepsis of the newborn includes Ramycin, Garamycin, Penicillin G Potassium In Plastic Container, Tobi, Vancocin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Sepsis of the newborn patent cliff · Sepsis of the newborn CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Tobi · Novartis
- Treatment: Vancocin · ANI Pharmaceuticals
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing